Received for publication August 11, 2005.
Revised September 19, 2005.
Accepted for publication September 30, 2005.

HUMAN IN VITRO GLUTATHIONYL AND PROTEIN ADDUCTS OF CARBAMAZEPINE-10,11-EPOXIDE, A STABLE AND PHARMACOLOGICALLY ACTIVE METABOLITE OF CARBAMAZEPINE

Abstract

The clinical use of carbamazepine (CBZ), an anticonvulsant, is associated with a variety of idiosyncratic adverse reactions that are likely related to the formation of chemically reactive metabolites. CBZ-10,11-epoxide (CBZE), a pharmacologically active metabolite of CBZ, is so stable in vitro and in vivo that the potential for the epoxide to covalently interact with macromolecules has not been fully explored. In this study, two glutathione (GSH) adducts were observed when CBZE was incubated with GSH in the absence of biological matrices and cofactors (e.g., liver microsomes and NADPH). The chemical reactivity of CBZE was further confirmed by the in vitro finding that [¹⁴C]CBZE formed covalent protein adducts in human plasma as well as in human liver microsomes (HLM) without NADPH. The two GSH adducts formed in the chemical reaction of CBZE were identical to the two major GSH adducts observed in the HLM incubation of CBZ, indicating that the 10,11-epoxidation represents a bioactivation pathway of CBZ. The two GSH adducts were isolated and identified as two diastereomers of 10-hydroxy-11-glutathionyl-CBZ by nuclear magnetic resonance spectroscopy (NMR). In addition, the covalent binding of [¹⁴C]CBZE was significantly increased in the HLM incubation upon addition of NADPH, indicating that CBZE can be further bioactivated by HLM. To our knowledge, this is the first time the metabolite CBZE has been confirmed for its ability to form covalent protein adducts and the identity of the two CBZE-glutathionyl adducts has been confirmed by NMR. These represent important findings in the bioactivation mechanism of CBZ.

Key words: bioactivation, covalent drug binding, cytochrome P450 catalyzed oxidations, drug toxicity, glutathione conjugates, idiosyncratic drug reactions, liver microsomes, mass spectrometry, reactive metabolites, structure elucidation

This article has been cited by other articles:

				W. Lu and J. P. Uetrecht Peroxidase-Mediated Bioactivation of Hydroxylated Metabolites of Carbamazepine and Phenytoin Drug Metab. Dispos., August 1, 2008; 36(8): 1624 - 1636. [Abstract] [Full Text] [PDF]

				R. E. Pearce, W. Lu, Y. Wang, J. P. Uetrecht, M. A. Correia, and J. S. Leeder Pathways of Carbamazepine Bioactivation in Vitro. III. The Role of Human Cytochrome P450 Enzymes in the Formation of 2,3-Dihydroxycarbamazepine Drug Metab. Dispos., August 1, 2008; 36(8): 1637 - 1649. [Abstract] [Full Text] [PDF]

				P. Kang, M. Liao, M. R. Wester, J. S. Leeder, R. E. Pearce, and M. A. Correia CYP3A4-Mediated Carbamazepine (CBZ) Metabolism: Formation of a Covalent CBZ-CYP3A4 Adduct and Alteration of the Enzyme Kinetic Profile Drug Metab. Dispos., March 1, 2008; 36(3): 490 - 499. [Abstract] [Full Text] [PDF]